Angiocrine Bioscience, Inc.
11575 Sorrento Valley Road
About Angiocrine Bioscience, Inc.
Angiocrine Bioscience Inc. (San Diego, CA, USA) is a privately held biopharmaceutical company with proprietary technologies consisting of a line of human engineered endothelial cells (E-CEL™) with applications in hematologic stem cell transplantation, ex vivo stem cell gene therapy and organ-specific regenerative therapies. Angiocrine has a unique, robust R&D pipeline and is entering the clinical stage in the near future. The Angiocrine team is united and fueled by its passion and sense of urgency to bring new, breakthrough cell-based treatments to patients suffering from dire medical conditions.